Literature DB >> 319054

Homologous and heterologous protection of mice with group A streptococcal M protein vaccines.

M K Wittner, E N Fox.   

Abstract

Purified streptococcal M proteins precipitated with alum (APM) were used to immunize mice. A trivalent vaccine of serotypes 1, 3, and 12 protected mice against challenges by homologous live streptococci and also conferred protection against serotypes 6 and 14 but not against a strain of group B streptococci. Monovalent APM vaccines afforded homologous protection and restricted heterologous protection. The extent of heterologous protection was a function of serotype combinations and was also dose dependent. Rabbit antisera exhibiting strong opsonic activities were active in vitro and in passive mouse protection only for homologous serotypes. Mouse antisera did not passively transfer protection and were not bactericidal in vitro. It was concluded that homologous and heterologous active mouse protection was most likely a result of shared antigenic determinants of the various M proteins although protection of mice could not be measured as a function of circulating anti-M antibodies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319054      PMCID: PMC421334          DOI: 10.1128/iai.15.1.104-108.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  ANTIGENICITY OF THE M PROTEINS OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  E N FOX
Journal:  J Immunol       Date:  1964-11       Impact factor: 5.422

Review 2.  M proteins of group A streptococci.

Authors:  E N Fox
Journal:  Bacteriol Rev       Date:  1974-03

3.  Cross-protection among serotypes of group A streptococci.

Authors:  S Bergner-Rabinowitz; I Ofek; M D Moody
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

4.  Dynamics in development of experimental streptococcal immunity in mice.

Authors:  J G Michael; B F Massell
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

5.  Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypes.

Authors:  M K Wittner
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers.

Authors:  E N Fox; R H Waldman; M K Wittner; A A Mauceri; A Dorfman
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  Enhanced resistance to streptococcal infection induced in mice by cell wall mucopeptide.

Authors:  J Rotta; T J Prendergast; W W Karakawa; C K Harmon; R M Krause
Journal:  J Exp Med       Date:  1965-11-01       Impact factor: 14.307

8.  The occurrence of two M antigens in certain group A streptococci related to type 14.

Authors:  G G WILEY; A T WILSON
Journal:  J Exp Med       Date:  1961-02-01       Impact factor: 14.307

9.  Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1957-10-01       Impact factor: 14.307

10.  Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans.

Authors:  E N Fox; M K Wittner; A Dorfman
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

View more
  6 in total

1.  Conservation of protective and nonprotective epitopes in M proteins of group A streptococci.

Authors:  L Miller; V Burdett; T P Poirier; L D Gray; E H Beachey; M A Kehoe
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

Review 2.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

3.  Recent advances in rheumatic fever control and future prospect: a WHO memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

4.  [Recent progress in the fight against acute arthritic rheumatism and future perspectives: WHO Memorandum].

Authors: 
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

Review 5.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci.

Authors:  J B Dale; I Ofek; E H Beachey
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.